[HTML][HTML] Strength in diversity: Understanding the pathways to herpes simplex virus reactivation

JB Suzich, AR Cliffe - Virology, 2018 - Elsevier
Herpes simplex virus (HSV) establishes a latent infection in peripheral neurons and can
periodically reactivate to cause disease. Reactivation can be triggered by a variety of stimuli …

[HTML][HTML] Disturbed Yin–Yang balance: Stress increases the susceptibility to primary and recurrent infections of herpes simplex virus type 1

C Yan, Z Luo, W Li, X Li, R Dallmann, H Kurihara… - … Pharmaceutica Sinica B, 2020 - Elsevier
Herpes simplex virus type 1 (HSV-1), a neurotropic herpes virus, is able to establish a
lifelong latent infection in the human host. Following primary replication in mucosal epithelial …

[HTML][HTML] Oncolytic virus-based hepatocellular carcinoma treatment: Current status, intravenous delivery strategies, and emerging combination therapeutic solutions

X Li, X Sun, B Wang, Y Li, J Tong - Asian journal of pharmaceutical …, 2023 - Elsevier
Current treatments for advanced hepatocellular carcinoma (HCC) have limited success in
improving patients' quality of life and prolonging life expectancy. The clinical need for more …

c-Jun signaling during initial HSV-1 infection modulates latency to enhance later reactivation in addition to directly promoting the progression to full reactivation

SA Dochnal, AL Whitford, AK Francois… - Journal of …, 2024 - Am Soc Microbiol
ABSTRACT Herpes simplex virus-1 (HSV-1) establishes a latent infection in peripheral
neurons and periodically reactivates to permit transmission, which can result in clinical …

“Non-essential” proteins of HSV-1 with essential roles in vivo: a comprehensive review

C Dogrammatzis, H Waisner, M Kalamvoki - Viruses, 2020 - mdpi.com
Viruses encode for structural proteins that participate in virion formation and include capsid
and envelope proteins. In addition, viruses encode for an array of non-structural accessory …

Comparison of clinically relevant oncolytic virus platforms for enhancing T cell therapy of solid tumors

V Cervera-Carrascon, DCA Quixabeira… - Molecular Therapy …, 2020 - cell.com
Despite some promising results, the majority of patients do not benefit from T cell therapies,
as tumors prevent T cells from entering the tumor, shut down their activity, or downregulate …

Swarms of chemically modified antiviral siRNA targeting herpes simplex virus infection in human corneal epithelial cells

K Kalke, LM Lund, MC Nyman, AA Levanova… - PLoS …, 2022 - journals.plos.org
Herpes simplex virus type 1 (HSV-1) is a common virus of mankind and HSV-1 infections are
a significant cause of blindness. The current antiviral treatment of herpes infection relies on …

Differentiated human SH-SY5Y cells provide a reductionist model of herpes simplex virus 1 neurotropism

MM Shipley, CA Mangold, CV Kuny… - Journal of virology, 2017 - Am Soc Microbiol
Neuron-virus interactions that occur during herpes simplex virus (HSV) infection are not fully
understood. Neurons are the site of lifelong latency and are a crucial target for long-term …

The role of viral proteins in the regulation of exosomes biogenesis

X Jia, Y Yin, Y Chen, L Mao - Frontiers in Cellular and Infection …, 2021 - frontiersin.org
Exosomes are membrane-bound vesicles of endocytic origin, secreted into the extracellular
milieu, in which various biological components such as proteins, nucleic acids, and lipids …

Herpesvirus-mediated stabilization of ICP0 expression neutralizes restriction by TRIM23

X Liu, D Acharya, E Krawczyk… - Proceedings of the …, 2021 - National Acad Sciences
Herpes simplex virus (HSV) infection relies on immediate early proteins that initiate viral
replication. Among them, ICP0 is known, for many years, to facilitate the onset of viral gene …